Medtronic plc — Director's Dealing 2017

Jan 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-01-05

Reporting Person: Lenehan James T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-05	Ordinary Shares	M	2586	$54.14	Acquired	42838	Direct
2017-01-05	Ordinary Shares	M	801	$54.14	Acquired	43639	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-05	Stock Option (Right to Buy)	$54.14	M	2586	Disposed	2017-01-18	Ordinary Shares (2586)	Direct
2017-01-05	Stock Option (Right to Buy)	$54.14	M	801	Disposed	2017-01-18	Ordinary Shares (801)	Direct

Footnotes

F1: This option to purchase 2,586 ordinary shares of New Medtronic for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,586 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F2: This option to purchase 801 New Medtronic ordinary shares for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 801 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.